Frontera Therapeutics is a startup based in the United States, 2 tracked investors.
Based in the United States, Frontera Therapeutics is a startup founded in 2020. Brouky records 2 investors associated with the company.
Frontera Therapeutics is a clinical-stage gene therapy company that develops AAV-based gene therapies using its EXACTE capsid and transgene engineering platform. Its pipeline includes programs targeting inherited retinal diseases (e.g., RPE65 and XLRP) and it operates internationally (US and China presence).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.